Journal article
How to manage patients with cardiopulmonary disease?
Best practice & research. Clinical rheumatology, v 16(2), pp 211-227
01 Apr 2002
PMID: 12041950
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Systemic lupus erythematosus (SLE) is a connective tissue disease characterized by the formation of autoantibodies and immune complexes. The heart and lungs are among the organ systems commonly affected in SLE. Pericarditis, premature coronary atherosclerosis, pleuritis and pulmonary infections are the most prevalent cardiopulmonary manifestations. Other rare associations include myocarditis, coronary arteritis, acute lupus pneumonitis/pulmonary haemorrhage, acute reversible hypoxaemia and ‘shrinking lung’ syndrome. Current imaging modalities may provide earlier detection of subclinical disease, which may aid in preventing these potentially fatal complications. The response to treatment varies, depending on the presentation of disease. In this chapter we address the frequency, diagnosis and monitoring, and treatment regimens of cardiac and pulmonary involvement in patients with SLE.
Metrics
Details
- Title
- How to manage patients with cardiopulmonary disease?
- Creators
- Amy H. Kao - University of PittsburghSusan Manzi - University of Pittsburgh
- Publication Details
- Best practice & research. Clinical rheumatology, v 16(2), pp 211-227
- Publisher
- Elsevier
- Number of pages
- 17
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- General Internal Medicine
- Web of Science ID
- WOS:000176489500005
- Scopus ID
- 2-s2.0-0036526748
- Other Identifier
- 991021933908704721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Rheumatology